Eastwood Stock Based Compensation To Revenue from 2010 to 2024
| EBM Stock | CAD 0.54 0.11 16.92% |
Stock Based Compensation To Revenue | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Eastwood Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eastwood Bio's main balance sheet or income statement drivers, such as Interest Expense of 34 K, Selling General Administrative of 858.4 K or Selling And Marketing Expenses of 2.8 K, as well as many indicators such as Price To Sales Ratio of 157, Ptb Ratio of 82.46 or Days Sales Outstanding of 17.89. Eastwood financial statements analysis is a perfect complement when working with Eastwood Bio Valuation or Volatility modules.
Eastwood | Stock Based Compensation To Revenue |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio's price analysis, check to measure Eastwood Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio is operating at the current time. Most of Eastwood Bio's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio's price. Additionally, you may evaluate how the addition of Eastwood Bio to your portfolios can decrease your overall portfolio volatility.